#United States #New York #Class Action #Gross Law Firm #Vistagen Therapeutics

Vistagen Therapeutics Class Action Alert

Investors who have suffered losses from Vistagen Therapeutics, Inc. (NASDAQ: VTGN) are encouraged to take action. Recent developments indicate a pending class action lawsuit filed by The Gross Law Firm. Shareholders who purchased shares during the designated class period of April 1, 2024, to December 16, 2025, should consider stepping forward to protect their interests.

Background on Vistagen Therapeutics

Vistagen Therapeutics is known for its research into treatments for anxiety and related disorders, particularly its investigational medication, fasedienol. This candidate had been under clinical trials to evaluate its effectiveness in treating social anxiety disorder. However, recent events have sparked concern among investors.

On December 17, 2025, Vistagen disclosed that the Phase 3 PALISADE-3 study of fasedienol did not yield statistically significant results regarding its primary endpoints. Statements made by the company leading up to this announcement were reportedly positive and did not reflect the disappointing trial outcomes.

This announcement led to a dramatic drop in Vistagen’s stock price, plummeting from $4.36 on December 16 to $0.86 per share the following day—an astounding decline exceeding 80%. Such a loss has understandably caused distress among shareholders, prompting the current class action effort.

Important Details for Investors

For those who have invested in Vistagen Therapeutics during the specified period, it is crucial to act swiftly. The Gross Law Firm suggests that registering as a shareholder is essential for anyone impacted by the plunge in stock value. Furthermore, individuals may also have an opportunity to be appointed as lead plaintiffs in the case. However, it is important to note that participating as a lead plaintiff isn’t a prerequisite for recovering any losses.

The deadline for registration is March 16, 2026. Investors can submit their information via the Gross Law Firm’s website to ensure they receive updates about the case's progress and further actions.

The Role of The Gross Law Firm

The Gross Law Firm is recognized for advocating for the rights of investors and aims to support those victimized by corporate misconduct. Their mission is to ensure that companies uphold appropriate business practices, and they are determined to pursue justice for individuals affected by misleading statements and fraudulent actions. Investors should not feel hesitated in seeking to recover their losses, as the firm operates on the principle that there are no fees or obligations required to participate.

Next Steps for Affected Shareholders

In light of the impending class action lawsuit, affected shareholders should:
1. Register: Ensure that your details are submitted before the March 16, 2026, cutoff date to be included in this significant legal action.
2. Monitor Updates: As an enrolled shareholder, you will gain access to a portfolio monitoring system, which will keep you informed about the case's developments.
3. Consult Legal Advisors: It may be advantageous to seek legal counsel to explore other options available in light of the financial impact.

With the stakes high and the opportunity for recovery on the horizon, Vistagen investors are strongly encouraged to take action. Your participation could be pivotal in reclaiming your losses and holding Vistagen accountable for its actions.

For more information or to register, visit The Gross Law Firm’s official site or contact the firm directly at (646) 453-8903 for personalized assistance.